Criminal Justice Settings: Buprenorphine & Fentanyl in E.R. and Adult Drug Treatment Courts, Jail and Prison-Recording - 2023-09-14 - Testimonies from The Trenches: Criminal Justice

Recording - 2023-09-14 - Testimonies from The Trenches: Criminal Justice

Video Transcription

Video Summary

Dr. William Moroney, a chief medical officer and medical director at Recovery Pathways, discussed various topics related to addiction medicine in a video presentation. He highlighted the importance of buprenorphine in treating opioid use disorder and its evolving role in different settings. Dr. Moroney emphasized the need to improve access to buprenorphine treatment in emergency departments, drug treatment courts, and jails. He also discussed the use of telemedicine and mobile units to reach individuals in rural areas. Dr. Moroney provided insights from his experience working in prison re-entry programs and highlighted the positive impact of medication-assisted treatment in reducing recidivism and overdose deaths. He also discussed the challenges of testing for fentanyl and the need for increased education and advocacy in the addiction field. Overall, Dr. Moroney stressed the importance of evidence-based treatment and the need for better integration of addiction medicine in various healthcare and criminal justice settings.

Keywords

Dr. William Moroney

addiction medicine

buprenorphine

opioid use disorder

treatment

access

telemedicine

medication-assisted treatment

recidivism

fentanyl testing

evidence-based treatment